Extracellular Vesicle-Based Drug Delivery Systems in Cancer Therapy

Int J Mol Sci. 2025 May 19;26(10):4835. doi: 10.3390/ijms26104835.

Abstract

Extracellular vesicles (EVs) are lipid bilayer-enclosed particles secreted by cells and ubiquitously present in various biofluids. They not only mediate intercellular communication but also serve as promising drug carriers that are capable of delivering therapeutic agents to target cells through their inherent physicochemical properties. In this review, we summarized the recent advances in EV isolation techniques and innovative drug-loading strategies. Furthermore, we emphasized the distinct advantages and therapeutic applications of EVs derived from different cellular sources in cancer treatment. Finally, we critically evaluated the ongoing clinical trials utilizing EVs for drug delivery and systematically assessed both the opportunities and challenges associated with implementing EV-based drug delivery systems in cancer therapy.

Keywords: biotherapy; cancer therapy; drug delivery; extracellular vesicles.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents* / administration & dosage
  • Antineoplastic Agents* / therapeutic use
  • Drug Carriers / chemistry
  • Drug Delivery Systems* / methods
  • Extracellular Vesicles* / chemistry
  • Extracellular Vesicles* / metabolism
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism

Substances

  • Antineoplastic Agents
  • Drug Carriers